Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Travere Therapeutics (NASDAQ:TVTX) through any online brokerage.
Other companies in Travere Therapeutics’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Ascentage Pharma Group International (NASDAQ:AAPG), Arcutis Biotherapeutics Inc (NASDAQ:ARQT) and Xenon Pharmaceuticals Inc (NASDAQ:XENE).
Travere Therapeutics has a consensus price target of $35.00.
The stock price for Travere Therapeutics (NASDAQ: TVTX) is $35.85 last updated December 16, 2025 at 5:22 PM EST.
There are no upcoming dividends for Travere Therapeutics.
Travere Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Travere Therapeutics.
Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.